LEXARIA BIOSCIENCE C

LEXX
Delayed Quote. Delayed  - 01/19 03:59:58 pm
4.34USD -5.24%

Turn to zoom
Prev.4.5800
Open4.5700
High4.7200
Low4.3400
Volume272 702
Latest news
4d ago
4d ago
4d ago
7d ago
Chart LEXARIA BIOSCIENCE CORP.
Financials
Sales 2020 0,38 M - -
Net income 2020 -3,93 M - -
Net cash 2020 1,16 M - -
P/E ratio 2020 -7,31x
Yield 2020 -
Capitalization 22,2 M 22,2 M -
EV / Sales 2019 238x
EV / Sales 2020 78,0x
Nbr of Employees 4
Free-Float 94,1%
Company
Lexaria Bioscience Corp is a healthcare company. The Company is primarily engaged in developing drug delivery technology, DehydraTECH, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness...

>> Read more
Sector :
Food Processing - NEC
Calendar :
No events available

Income Statement Evolution